Polycyclo Ring System Having The Five-membered Hetero Ring As One Of The Cyclos Patents (Class 546/276.7)
  • Patent number: 10458915
    Abstract: The present invention provides heteroaryl functionalized cyanine dyes including a reactive functional moiety, or which are conjugated to a carrier molecule.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: October 29, 2019
    Assignee: Pacific Biosciences of California, Inc.
    Inventors: Stephen Yue, Gene Shen, Wei-Chuan Sun
  • Patent number: 9799834
    Abstract: A novel carbazole compound is provided which can be used as a host material for a light-emitting substance (substance emitting fluorescence or substance emitting phosphorescence). A light-emitting element with high emission efficiency, and a light-emitting device, an electronic device, or a lighting device which has low power consumption are provided. A carbazole compound represented by General Formula (G1) below. (In the formula, Ar1 represents any of hydrogen, a substituted or unsubstituted phenyl group, and a carbazolyl group; R1 to R3 each independently represent any of hydrogen, a substituted or unsubstituted phenyl group, and a substituted or unsubstituted biphenyl group; ? represents any of a substituted or unsubstituted phenylene group and a substituted or unsubstituted biphenylene group; and n is any of 0, 1, and 2.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: October 24, 2017
    Assignee: Semiconductor Energy Laboratory Co., Ltd.
    Inventors: Harue Osaka, Nobuharu Ohsawa, Masato Suzuki
  • Patent number: 9653690
    Abstract: An organic compound represented by Chemical Formula 1, an organic optoelectric device including the organic compound, and a display device are disclosed.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: May 16, 2017
    Assignee: SAMSUNG SDI CO., LTD.
    Inventors: Han-Ill Lee, Eun-Sun Yu, Dong-Min Kang, Eui-Su Kang, Soo-Hyun Min, Yong-Tak Yang, Jae-Jin Oh, Dong-Kyu Ryu, Sang-Shin Lee, Yu-Na Jang, Soo-Young Jeong, Young-Kyoung Jo, Su-Jin Han, Jin-Seok Hong
  • Patent number: 9388168
    Abstract: The present invention relates to a novel process for the preparation of of the formula (I) (I) wherein R1 and R2 are described herein. The compounds prepared by the present invention are useful in the synthesis and manufacture of compounds for treating diseases or conditions associated with inhibiting actin polymerization.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: July 12, 2016
    Assignee: HUA MEDICINE
    Inventors: Junli Chen, Yi Ren, Jin She, Lin Wang
  • Patent number: 9328090
    Abstract: The present invention relates to ethynyl derivatives of formula I wherein R1 is phenyl, which is optionally substituted by 1-2 halogen atoms; selected from fluorine or chlorine; or to a pharmaceutically acceptable acid addition salt in enantiomerically pure form. It has been found that the compounds of general formula I are allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5).
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: May 3, 2016
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Georg Jaeschke, Lothar Lindemann, Heinz Stadler, Eric Vieira
  • Patent number: 9315864
    Abstract: Heteroaryl cyanine dyes bearing sulfonic acid substituents are of use in various assays, including single molecule nucleic acid sequencing. Exemplary heteroaryl cyanines dyes include or more reactive functional group, which is of use to covalently conjugate the cyanine dye to a carrier molecule. An exemplary carrier molecule is an analyte molecule or other molecule of interest, for example, a nucleotide oligophosphate.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: April 19, 2016
    Assignee: Pacific Biosciences of California, Inc.
    Inventors: Stephen Yue, Gene Shen, Wei-Chuan Sun
  • Patent number: 9126932
    Abstract: The present invention relates to certain substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 receptor-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, microbial infections or diseases and viral infections or diseases.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: September 8, 2015
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Robert M. Jones, Daniel J. Buzard, Sangdon Han, Sun Hee Kim, Juerg Lehmann, Brett Ullman, Jeanne V. Moody, Xiuwen Zhu, Scott Stim
  • Publication number: 20150133505
    Abstract: The present invention relates to ethynyl derivatives of formula I wherein R1 is phenyl, which is optionally substituted by 1-2 halogen atoms; selected from fluorine or chlorine; or to a pharmaceutically acceptable acid addition salt in enantiomerically pure form. It has been found that the compounds of general formula I are allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5).
    Type: Application
    Filed: January 15, 2015
    Publication date: May 14, 2015
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Georg Jaeschke, Lothar Lindemann, Heinz Stadler, Eric Vieira
  • Patent number: 9029558
    Abstract: A novel carbazole compound is provided which can be used as a host material for a light-emitting substance (substance emitting fluorescence or substance emitting phosphorescence). A light-emitting element with high emission efficiency, and a light-emitting device, an electronic device, or a lighting device which has low power consumption are provided. A carbazole compound represented by General Formula (G1) below. (In the formula, Ar1 represents any of hydrogen, a substituted or unsubstituted phenyl group, and a carbazolyl group; R1 to R3 each independently represent any of hydrogen, a substituted or unsubstituted phenyl group, and a substituted or unsubstituted biphenyl group; ? represents any of a substituted or unsubstituted phenylene group and a substituted or unsubstituted biphenylene group; and n is any of 0, 1, and 2.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: May 12, 2015
    Assignee: Semiconductor Energy Laboratory Co., Ltd.
    Inventors: Harue Osaka, Nobuharu Ohsawa, Masato Suzuki
  • Patent number: 9023340
    Abstract: Methods and small molecule compounds for stem cell differentiation and treatment of animals with diseases are provided. One example of a class of compounds that may be used is represented by the compound of Formula I and II: or a pharmaceutically acceptable salt or solvate thereof, wherein A, X, Q, R1, R2, R3, R4 are as described herein.
    Type: Grant
    Filed: July 2, 2012
    Date of Patent: May 5, 2015
    Assignee: ChemRegen, Inc.
    Inventors: John Cashman, Marion Lanier, Mark Mercola, Dennis Schade, Erik Willems
  • Publication number: 20150119384
    Abstract: The present invention relates to ethynyl derivatives of formula I X, O, R1, R2, R3, R3?, R4, R4?, R5, R6, R6?, m, and n are as defined hereinor to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof. Compounds of formula I are positive allosteric modulators (PAM) of the metabotropic glutamate receptor subtype 5 (mGluR5). They can be used for the treatment of schizophrenia or cognitive disorders.
    Type: Application
    Filed: January 6, 2015
    Publication date: April 30, 2015
    Inventors: Georg Jaeschke, Synese Jolidon, Lothar Lindemann, Heinz Stadler, Eric Vieira
  • Publication number: 20150115232
    Abstract: A chrysene-based compound and an organic light-emitting device including the same, the chrysene-based compound being represented by Formula 1, below:
    Type: Application
    Filed: April 17, 2014
    Publication date: April 30, 2015
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Kwang-Hyun KIM, Young-Kook KIM, Eun-Young LEE
  • Patent number: 9017827
    Abstract: A compound for an organic optoelectronic device, an organic light emitting diode, and a display device, the compound including sequentially combined substituents represented by the following Chemical Formulae 1 to 3:
    Type: Grant
    Filed: December 23, 2011
    Date of Patent: April 28, 2015
    Assignee: Cheil Industries, Inc.
    Inventors: Sung-Hyun Jung, Hyung-Sun Kim, Ho-Jae Lee, Eun-Sun Yu, Mi-Young Chae, Ja-Hyun Kim
  • Publication number: 20150105548
    Abstract: The present invention relates to anti-HCV compounds, compositions comprising the same and methods of using the same to treat HCV infection.
    Type: Application
    Filed: May 25, 2012
    Publication date: April 16, 2015
    Inventors: Allan Krueger, Warren M. Kati, Clarence J. Maring, Rolf Wagner, Charles W. Hutchins
  • Publication number: 20150090964
    Abstract: A compound represented by Formula 1 or Formula 2 and an organic light-emitting device including the same:
    Type: Application
    Filed: March 5, 2014
    Publication date: April 2, 2015
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Seok-Hwan Hwang, Soo-Yon Kim, Jong-Woo Kim
  • Publication number: 20150090965
    Abstract: A compound represented by Formula 1 or 2, and an organic light-emitting device including the same are disclosed. Formulae 1 and 2 are defined as in the specification.
    Type: Application
    Filed: April 2, 2014
    Publication date: April 2, 2015
    Applicant: Samsung Display Co., Ltd.
    Inventors: Jun-Ha Park, Mi-Eun Jun, Eun-Jae Jeong
  • Publication number: 20150090968
    Abstract: A condensed cyclic compound represented by Formula 1: wherein in Formula 1, Groups X1 to X3, L11, L12, R11, and R12, and variables a11, a12, b11, b12, c11, and c12 are described in the specification.
    Type: Application
    Filed: June 2, 2014
    Publication date: April 2, 2015
    Applicants: Samsung Electronics Co., Ltd., CHEIL INDUSTRIES INC.
    Inventors: Chang-woo KIM, O-hyun KWON, Sang-dong KIM, Kyu-young HWANG, Byoung-ki CHOI
  • Publication number: 20150090967
    Abstract: A pyrene-based compound is represented by Formula 1: where R11 to R14, L11, m11, n11, k11, a12, a13, and a14 are as defined in the specification.
    Type: Application
    Filed: May 29, 2014
    Publication date: April 2, 2015
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Eun-Young LEE, Kwang-Hyun KIM, Young-Kook KIM
  • Patent number: 8987462
    Abstract: Provided are a compound of Formula 1 and an organic light-emitting device including the compound of Formula 1: The compounds of Formula 1 are particularly useful as fluorescent dopants in the emission layer of the organic light-emitting device.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: March 24, 2015
    Assignees: Samsung Display Co., Ltd., Pusan National University Industry—University Cooperation Foundation
    Inventors: Soung-Wook Kim, Myeong-Suk Kim, Jae-Hong Kim, Jin-Soo Hwang, Hong-Suk Suh
  • Publication number: 20150080362
    Abstract: The present description relates to compounds and forms and pharmaceutical compositions thereof and methods for use thereof to treat or ameliorate bacterial infections caused by wild-type and multi-drug resistant Gram-negative and Gram-positive pathogens.
    Type: Application
    Filed: August 29, 2012
    Publication date: March 19, 2015
    Applicant: PTC THERAPEUTICS, INC.
    Inventors: Arthur Branstrom, Vara Prasad Venkata Nagendra Josyula, Michael Andrew Arnold, Aleksey I. Gerasyuto, Gary Karp, Jiashi Wang, Tamil Arasu, John David Baird, Wu Du, Olya Ginzburg, Yi Jin Kim Gorske, Jana Narasimhan, Srinivasa Peddi, Hongyan Qi, Sean Wesley Smith, Anthony Allan Turpoff, Richard Gerald Wilde, Tianle Yang, Nanjing Zhang, Xiaoyan Zhang
  • Publication number: 20150080576
    Abstract: Compounds, pharmaceutical compositions including the compounds, and methods of preparation and use thereof are disclosed. The compounds are amide compounds which can be prepared from certain heteroaryl carboxylic acids and certain diazabicycloalkanes. The compounds exhibit selectivity for, and bind with high affinity to, neuronal nicotinic receptors of the ?4?2 subtype in the central nervous system (CNS). The compounds and compositions can be used to treat and/or prevent a wide variety of conditions or disorders, particularly CNS disorders. The compounds can: (i) alter the number of nicotinic cholinergic receptors of the brain of the patient, (ii) exhibit neuroprotective effects, and (iii) when employed in effective amounts, not result in appreciable adverse side effects (e.g. side effects such as significant increases in blood pressure and heart rate, significant negative effects upon the gastrointestinal tract, and significant effects upon skeletal muscle).
    Type: Application
    Filed: November 24, 2014
    Publication date: March 19, 2015
    Inventors: Anatoly Mazurov, Lan Miao, Yunde Xiao, Philip S. Hammond, Craig H. Miller, Srinivasa Rao Akireddy, Srinivasa V. Murthy, Regina C. Whitaker, Scott R. Breining, Matt S. Melvin
  • Publication number: 20150069347
    Abstract: A condensed cyclic compound and an organic light-emitting device including the same, the condensed cyclic compound being represented by Formula 1:
    Type: Application
    Filed: June 3, 2014
    Publication date: March 12, 2015
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Kwang-Hyun KIM, Seok-Hwan HWANG, Young-Kook KIM, Jun-Ha PARK, Hye-Jin JUNG, Eun-Young LEE, Jong-Woo KIM, Jin-O LIM, Sang-Hyun HAN, Eun-Jae JEONG, Soo-Yon KIM
  • Publication number: 20150069368
    Abstract: A compound for an organic photoelectric device, the compound being represented by the following Chemical Formula (“CF”) 1:
    Type: Application
    Filed: October 20, 2014
    Publication date: March 12, 2015
    Inventors: Hyung-Sun KIM, Eun-Sun YU, Young-Hoon KIM, Soo-Hyun MIN, Ho-Jae LEE, Eui-Su KANG, Mi-Young CHAE
  • Publication number: 20150069342
    Abstract: A condensed-cyclic compound represented by Formula 1 and an organic light-emitting device including the condensed-cyclic compound. wherein R1 to R10 are defined as in the specification.
    Type: Application
    Filed: May 1, 2014
    Publication date: March 12, 2015
    Applicant: Samsung Display Co., Ltd.
    Inventors: Eun-Young Lee, Seok-Hwan Hwang, Young-Kook Kim, Jun-Ha Park, Hye-Jin Jung, Jin-O Lim, Jong-Woo Kim, Sang-Hyun Han, Kwang-Hyun Kim, Eun-Jae Jeong, Soo-Yon Kim
  • Publication number: 20150069355
    Abstract: Provided are a condensed compound and an organic light-emitting diode including the same, the condensed compound being represented by Formula 1 or 2:
    Type: Application
    Filed: July 30, 2014
    Publication date: March 12, 2015
    Inventors: Seok-Hwan HWANG, Young-Kook KIM, Jun-Ha PARK, Hye-Jin JUNG, Jin-O LIM, Eun-Young LEE, Jong-Woo KIM, Sang-Hyun HAN, Kwang-Hyun KIM, Eun-Jae JEONG, Soo-Yon KIM
  • Publication number: 20150060787
    Abstract: Provided is a compound represented by Formula 1, Formula 2, or Formula 3:
    Type: Application
    Filed: May 21, 2014
    Publication date: March 5, 2015
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Jun-Ha PARK, Seok-Hwan HWANG, Young-Kook KIM, Hye-Jin JUNG, Eun-Young LEE, Jong-Woo KIM, Jin-O LIM, Sang-Hyun HAN, Eun-Jae JEONG, Soo-Yon KIM
  • Patent number: 8969352
    Abstract: The present invention is directed to compounds of Formula I: wherein X is N or CR1; Y is N or CR2; R1 is H, alkoxy, halo, triazolyl, pyrimidinyl, oxazolyl, isoxazole, oxadiazolyl, or pyrazolyl; R2 is H, alkyl, alkoxy, or halo; Z is NH or O; R3 is H, alkyl, alkoxy, halo, or triazolyl; R4 is H or alkyl; or R3 and R4, together with the atoms to which they are attached, form a 6-membered aryl ring or a 5- or 6-membered heteroaryl ring; R5 is pyridyl, pyrazinyl, or pyrimidinyl, wherein the pyridyl, pyrazinyl, or pyrimidinyl is optionally substituted with halo or alkyl; and n is 1 or 2. Methods of making the compounds of Formula I are also described. The invention also relates to pharmaceutical compositions comprising compounds of Formula I. Methods of using the compounds of the invention are also within the scope of the invention.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: March 3, 2015
    Assignee: Janssen Pharmaceutica NV
    Inventors: Christine F. Gelin, Terry P. Lebold, Brock T. Shireman
  • Publication number: 20150053941
    Abstract: A heterocyclic compound and an organic light-emitting diode including the same, the heterocyclic compound being represented by Formula 1, below:
    Type: Application
    Filed: May 22, 2014
    Publication date: February 26, 2015
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Hye-Jin JUNG, Seok-Hwan HWANG, Young-Kook KIM, Jun-Ha PARK, Eun-Young LEE, Jong-Woo KIM, Jin-O LIM, Sang-Hyun HAN, Kwang-Hyun KIM, Eun-Jae JEONG, Soo-Yon KIM
  • Patent number: 8962158
    Abstract: Provided is an organic electroluminescent device (organic EL device), which has improved luminous efficiency, has sufficient driving stability, and has a simple construction. The organic EL device of the present invention is an organic electroluminescent device, including a light-emitting layer and a hole-transporting layer between an anode and a cathode laminated on a substrate, in which the light-emitting layer contains a phosphorescent light-emitting dopant and an indolocarbazole compound that serves as a host material, or alternatively, the hole-transporting layer contains an indolocarbazole compound. The indolocarbazole compound is represented by the following formula (1). In the formula: A1's each represent an aromatic hydrocarbon group or an aromatic heterocyclic group, provided that at least one of A1's has a fused ring structure; and R1's each represent a hydrogen atom, an alkyl group, an alkoxy group, or an acyl group.
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: February 24, 2015
    Assignee: Nippon Steel & Sumikin Chemical Co., Ltd.
    Inventors: Masaki Komori, Takahiro Kai, Toshihiro Yamamoto
  • Publication number: 20150041773
    Abstract: An anthracene-based compound is represented by Formula 1 as below: wherein Ar, R1 to R3, R11 to R13, L1, L2, a1 to a3, b1, b2, n1, n2, m1, m2, o1 and o2 are as defined in the specification. An organic light-emitting device includes the anthracene-based compound.
    Type: Application
    Filed: May 21, 2014
    Publication date: February 12, 2015
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Jun-Ha PARK, Seok-Hwan HWANG, Young-Kook KIM, Hye-Jin JUNG, Eun-Young LEE, Jong-Woo KIM, Jin-O LIM, Sang-Hyun HAN, Kwang-Hyun KIM, Eun-Jae JEONG, Soo-Yon KIM
  • Publication number: 20150038437
    Abstract: The present description relates to compounds and forms and pharmaceutical compositions thereof and methods for use thereof to treat or ameliorate bacterial infections caused by wild-type and multi-drug resistant Gram-negative and Gram-positive pathogens.
    Type: Application
    Filed: August 29, 2012
    Publication date: February 5, 2015
    Applicant: PTC THERAPEUTICS, INC.
    Inventors: Arthur Branstrom, Vara Prasad Venkata Nagendra Josyula, Michael Andrew Arnold, Aleksey I. Gerasyuto, Gary Karp, Jiashi Wang, John David Baird, Guangming Chen, Olya Ginzburg, Jana Narasimhan, Srinivasa Peddi, Hongyan Qi, Sean Wesley Smith, Matthew G. Woll, Tianle Yang, Nanjing Zhang, Xiaoyan Zhang
  • Publication number: 20150021577
    Abstract: A novel organic compound that can be used as a carrier-transport material, a host material, or a light-emitting material in a light-emitting element is provided. Specifically, an organic compound that can give a light-emitting element having favorable characteristics even when the organic compound is used in a light-emitting element emitting phosphorescence is provided. The organic compound has a bipyridine skeleton formed by two pyridine skeletons to each of which a dibenzothiophenyl group or a dibenzofuranyl group is bonded via an arylene group.
    Type: Application
    Filed: July 16, 2014
    Publication date: January 22, 2015
    Inventors: Hiroshi Kadoma, Satomi Mitsumori, Yuko Kawata, Takao Hamada, Satoshi Seo
  • Publication number: 20150008423
    Abstract: A biscarbazole derivative of the invention is represented by a formula (1) below. In the formula (1): A1 represents a substituted or unsubstituted nitrogen-containing heterocyclic group having 1 to 30 ring carbon atoms; A2 represents a substituted or unsubstituted aromatic hydrocarbon group having 6 to 30 ring carbon atoms, or substituted or unsubstituted nitrogen-containing heterocyclic group having 1 to 30 ring carbon atoms; X1 and X2 each are a linking group; Y1 to Y4 each represent a substituent; p and q represent an integer of 1 to 4; and r and s represent an integer of 1 to 3.
    Type: Application
    Filed: September 22, 2014
    Publication date: January 8, 2015
    Applicant: IDEMITSU KOSAN CO., LTD.
    Inventors: Tetsuya INOUE, Mitsunori ITO, Kei YOSHIDA, Kumiko HIBINO, Kazuki NISHIMURA, Toshinari OGIWARA, Kiyoshi IKEDA
  • Patent number: 8921832
    Abstract: The present invention relates to a novel compound and an organic light emitting device using the compound, and the compound according to the present invention may largely improve a life span, efficiency, electrochemical stability and thermal stability of the organic light emitting device.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: December 30, 2014
    Assignee: LG Chem, Ltd.
    Inventors: Dae-Woong Lee, Sung-Kil Hong, Tae-Yoon Park, Yeon-Hwan Kim, Seong-So Kim
  • Publication number: 20140374724
    Abstract: The present invention relates to a novel indole-based compound having superior hole injection and transport capabilities, light-emitting capabilities, and the like, and an organic electroluminescent device which comprises the indole-based compound in one or more organic layers thereof so as to thereby achieve improved characteristics, such as light-emitting efficiency, driving voltage, and lifespan characteristics.
    Type: Application
    Filed: December 7, 2012
    Publication date: December 25, 2014
    Applicant: DOOSAN CORPORATION
    Inventors: Hoe Moon Kim, Sung Moo Kim, Young Bae Kim, Tae Hyung Kim, Ho Cheol Park, Chang Jun Lee, Young Mi Baek, Jin Yong Shin
  • Publication number: 20140367657
    Abstract: A heterocyclic compound, an organic light-emitting device, and a flat panel display apparatus, the compound being represented by Formula 1, below:
    Type: Application
    Filed: January 29, 2014
    Publication date: December 18, 2014
    Applicants: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, Samsung Display Co., Ltd.
    Inventors: Jae-Hong KIM, Myeong-Suk KIM, Soung-Wook KIM, Hong-Suk SUH, Jin-Soo HWANG
  • Publication number: 20140371461
    Abstract: The present invention provides a process for effectively producing an N-(hetero)arylazole with high yield, which is useful as a medical or agrochemical product, an organic photoconductor material, an organic electroluminescent element material, or the like. The present invention relates to a process for producing an N-(hetero)arylazole, which includes reacting a (hetero)aryl (pseudo)halide with an NH-azole in the presence of: a catalyst including a palladium compound and a coordination compound; and a basic magnesium compound.
    Type: Application
    Filed: August 31, 2012
    Publication date: December 18, 2014
    Applicant: TAKASAGO INTERNATIONAL CORPORATION
    Inventors: Yuji Nakayama, Tohru Kobayashi
  • Publication number: 20140361267
    Abstract: Provided is a heterocyclic compound represented by Formula 1 below and an organic light-emitting device including the same. In Formula 1, R1 to R8 are each independently a hydrogen atom, a deuterium atom, a substituted or unsubstituted C1 to C60 alkyl group, a substituted or unsubstituted C3 to C60 cycloalkyl group, a substituted or unsubstituted C2 to C60 heteroaryl group, a substituted or unsubstituted C6 to C60 aryl group, or a substituted or unsubstituted C6 to C60 condensed polycyclic group, with the proviso that R2 is not wherein X is O, S, or Se.
    Type: Application
    Filed: April 11, 2014
    Publication date: December 11, 2014
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Soo-Yon KIM, Seok-Hwan HWANG, Young-Kook KIM, Jun-Ha PARK, Hye-Jin JUNG, Eun-Young LEE, Sang-Hyun HAN, Jin-O LIM, Eun-Jae JEONG, Jong-Hyuk LEE
  • Publication number: 20140361268
    Abstract: A heterocyclic compound represented by Formula 1 below and an organic light-emitting device including the heterocyclic compound are provided:
    Type: Application
    Filed: April 22, 2014
    Publication date: December 11, 2014
    Applicant: Samsung Display Co., Ltd.
    Inventors: Seok-Hwan HWANG, Young-Kook KIM, Jun-Ha PARK, Hye-Jin JUNG, Jin-O LIM, Eun-Young LEE, Sang-Hyun HAN, Eun-Jae JEONG, Soo-Yon KIM, Jong-Hyuk LEE
  • Patent number: 8906911
    Abstract: Disclosed herein are chemokine receptor antagonists of formula (I) wherein R1, R2, and R3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: December 9, 2014
    Assignee: AbbVie Inc.
    Inventors: Michael D. Meyer, Xueqing Wang, Tao Guo, Robert Guo Ping Wei, Lijuan Jane Wang
  • Publication number: 20140357674
    Abstract: Compounds and compositions for promoting smoking cessation or decreasing tobacco use or nicotine addiction are provided. The compounds are 2?-fluoro-3?-(substituted phenyl) deschloroepibatidine analogs. The compounds have been found to modulate neuronal nicotine acetylcholine receptors and are useful in methods for the treatment of conditions or disorders influenced by the modulation of neuronal nicotinic acetylcholine receptors.
    Type: Application
    Filed: December 26, 2012
    Publication date: December 4, 2014
    Inventors: Frank Ivy Carroll, Pauline Wanjiku Ondachi, Hernan A. Navarro, M. Imad Damaj, James H. Woods, Emily M. Jutkiewicz
  • Patent number: 8901139
    Abstract: The present invention relates to Tricyclic Indole Derivatives, compositions comprising at least one Tricyclic Indole Derivatives, and methods of using the Tricyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
    Type: Grant
    Filed: June 10, 2009
    Date of Patent: December 2, 2014
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Srikanth Venkatraman, Anilkumar Gopinadhan Nair, Kevin X. Chen, Francisco Velazquez, Qingbei Zeng, Duan Liu, Yueheng Jiang, Joseph A. Kozlowski, F. George Njoroge, Stuart B. Rosenblum, Stephen J. Gavalas, Patrick A. Pinto, Oleg B. Selyutin, Bancha Vibulbhan
  • Publication number: 20140350247
    Abstract: An aryl amine derivative and an organic electroluminescent device using the aryl amine derivative as a hole transport material, the aryl amine derivative being represented by the following Chemical Formula 1.
    Type: Application
    Filed: May 22, 2014
    Publication date: November 27, 2014
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventor: Ichiro IMADA
  • Publication number: 20140346483
    Abstract: Disclosed are a compound for an organic optoelectronic device, an organic light emitting diode including the same, and a display device including the organic light emitting diode. The compound for an organic optoelectronic device represented by a combination of the following Chemical Formula 1; and Chemical Formula 2 or 3 provides an organic light emitting diode having life-span characteristics due to excellent electrochemical and thermal stability, and high luminous efficiency at a low driving voltage.
    Type: Application
    Filed: September 25, 2012
    Publication date: November 27, 2014
    Inventors: Eun-Sun Yu, Moo-Jin Park, Ho-Jae Lee, Mi-Young Chae
  • Publication number: 20140343077
    Abstract: A compound of formula (I) useful for the treatment or prevention of hepatitis C viral infection, (Formula (I)) wherein: X1 and X2 are each independently CRB or N; RB is H, (C1-6)alkyl, (C1-6)haloalkyl, halo.
    Type: Application
    Filed: August 22, 2012
    Publication date: November 20, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Christian Brochu, Chantal Grand-Maitre, Lee Fader, Cyrille Kuhn, Megan Bertrand-Laperle, Marc Pesant
  • Publication number: 20140343065
    Abstract: 3-aza-bicyclo[3.1.0]hexane-6-carboxylic acid amide derivatives which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4.
    Type: Application
    Filed: May 12, 2014
    Publication date: November 20, 2014
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Riccardo GIOVANNINI, Yunhai CUI, Henri DOODS, Marco FERRARA, Stefan JUST, Raimund KUELZER, Iain LINGARD, Rocco MAZZAFERRO, Klaus RUDOLF
  • Publication number: 20140332772
    Abstract: A styryl-based compound represented by Formula 1 below is disclosed. An organic light-emitting diode including the styryl-based compound is also disclosed.
    Type: Application
    Filed: November 8, 2013
    Publication date: November 13, 2014
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Sang-Hyun Han, Seok-Hwan Hwang, Young-Kook Kim, Hye-Jin Jung, Jin-O Lim, Soo-Yon Kim, Eun-Jae Jeong, Jun-Ha Park, Eun-Young Lee, Jong-Hyuk Lee
  • Patent number: 8884029
    Abstract: A photoelectric conversion device capable of improving conversion efficiency is provided. The photoelectric conversion device includes a work electrode, an opposed electrode, and an electrolyte-containing layer. In the work electrode, a metal oxide semiconductor layer supporting a dye is provided. The dye contains a cyanine compound that has a methine chain, an indolenine skeleton bonded with both ends of the methine chain, and anchor groups introduced to a nitrogen atom included in the indolenine skeleton. Electron injection efficiency to the metal oxide semiconductor layer is improved, and the dye is hardly exfoliated from the metal oxide semiconductor layer.
    Type: Grant
    Filed: September 9, 2009
    Date of Patent: November 11, 2014
    Assignee: Adeka Corporation
    Inventors: Junji Tanabe, Atsushi Monden, Masahiro Shinkai, Mitsuhiro Okada, Toru Yano, Yohei Aoyama, Yusuke Kubota
  • Publication number: 20140326970
    Abstract: New carbazole-based compounds are provided that are useful as host materials for singlelayer and multilayer organic light-emitting diode (OLED) devices. Highly efficient single-layer OLEDs have been demonstrated using new N-heterocyclic carbazole-based host materials. Phosphorescent OLEDs with a structure of ITO/MoO3/host/host:dopant/host/Cs2CO3/Al have been fabricated in which the new host materials act simultaneously as electron-transport, holetransport and host layer. Using this design, devices with maximum current and external quantum efficiencies of 92.2 cd and 26.8% were achieved, the highest reported to date for a single-layer OLED.
    Type: Application
    Filed: May 2, 2014
    Publication date: November 6, 2014
    Inventors: Zachary M. Hudson, Suning Wang, Michael G. Helander, Zhibin Wang, Zheng-Hong Lu
  • Publication number: 20140326987
    Abstract: A compound represented by Formula 1. An organic electric element includes a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrode. The organic material layer includes the compound represented by Formula 1. When the organic electric element includes the compound in the organic material layer, luminous efficiency, stability, and life span can be improved.
    Type: Application
    Filed: November 13, 2012
    Publication date: November 6, 2014
    Inventors: Junghwan Park, Sunhee Lee, Soungyun Mun, Daesung Kim, Hwasoon Jung, Wonsam Kim, Jihun Byun, Bumsung Lee